HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- O- octadecyl- sn- glycero- 3- phospho- acyclovir

structure given in first source

Also Known As:

ODG-P-ACV

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purinones: 2
        Hypoxanthines: 1
        Guanine: 1793
        Acyclovir: 4814
        1-O-octadecyl-sn-glycero-3-phospho-acyclovir: 1

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 06/15/1997 - "We synthesized 1-O-octadecyl-sn-glycero-3-phospho-acyclovir (ODG-P-ACV), 1-O-hexadecylpropanediol-3-phospho-acyclovir (HDP-P-ACV), and 1-O-octadecyl-sn-glycero-3-phospho-azidothymidine (ODG-P-AZT), and evaluated their antiviral activity in human hepatoma cells that constitutively produce HBV (2.2.15 cells). "
2.	Hepatitis B 06/15/1997 - "Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro."

Related Drugs and Biologics

1.	1- O- octadecyl- sn- glycero- 3- phospho- acyclovir
2.	Antiviral Agents (Antivirals)